96 related articles for article (PubMed ID: 32414566)
1. Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C.
Kangas-Dick A; Gall V; Hilden P; Turner A; Greenbaum A; Sesti J; Paul S; Carpizo D; Kennedy T; Sadaria Grandhi M; Alexander HR; Wang S; Geffner S; August D; Langan RC
Surgery; 2020 Jul; 168(1):49-55. PubMed ID: 32414566
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
3. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
Lam PH; Obirieze AC; Ortega G; Nwokeabia I; Onyewu S; Purnell SD; Samimi MM; Weeks CB; Lee EL; Shokrani B; Frederick WA; Callender CO; Wilson LL
Transplant Proc; 2016; 48(1):123-7. PubMed ID: 26915856
[TBL] [Abstract][Full Text] [Related]
6. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.
Wong RJ; Corley DA
Dig Dis Sci; 2009 Sep; 54(9):2031-9. PubMed ID: 19117131
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
[TBL] [Abstract][Full Text] [Related]
8. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.
Sonnenday CJ; Dimick JB; Schulick RD; Choti MA
J Gastrointest Surg; 2007 Dec; 11(12):1636-46; discussion 1646. PubMed ID: 17912593
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in hospital utilization in intracerebral hemorrhage.
Cruz-Flores S; Rodriguez GJ; Chaudhry MRA; Qureshi IA; Qureshi MA; Piriyawat P; Vellipuram AR; Khatri R; Kassar D; Maud A
Int J Stroke; 2019 Oct; 14(7):686-695. PubMed ID: 30868940
[TBL] [Abstract][Full Text] [Related]
10. Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
Costentin CE; Sogni P; Falissard B; Barbare JC; Bendersky N; Farges O; Goutte N
Dig Dis Sci; 2020 Jan; 65(1):301-311. PubMed ID: 31346950
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study.
Magnetta MJ; Xing M; Zhang D; Kim HS
J Vasc Interv Radiol; 2016 Dec; 27(12):1822-1828. PubMed ID: 27692856
[TBL] [Abstract][Full Text] [Related]
12. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the treatment of hepatocellular carcinoma based on geographical region are decreasing.
Sobotka LA; Hinton A; Conteh LF
J Gastroenterol Hepatol; 2019 Mar; 34(3):575-579. PubMed ID: 30345600
[TBL] [Abstract][Full Text] [Related]
14. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
15. Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
Kim D; Konyn P; Cholankeril G; Wong RJ; Younossi ZM; Ahmed A;
Gastroenterology; 2020 Oct; 159(4):1558-1560.e2. PubMed ID: 32389664
[No Abstract] [Full Text] [Related]
16. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report.
Alkhouli M; Holmes DR; Carroll JD; Li Z; Inohara T; Kosinski AS; Szerlip M; Thourani VH; Mack MJ; Vemulapalli S
JACC Cardiovasc Interv; 2019 May; 12(10):936-948. PubMed ID: 31122351
[TBL] [Abstract][Full Text] [Related]
18. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
Xu J; Li J; Chen J; Liu ZJ
Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
[TBL] [Abstract][Full Text] [Related]
19. Effects of Medicaid expansion on disparities in trauma care and outcomes in young adults.
Akande M; Minneci PC; Deans KJ; Xiang H; Chisolm DJ; Cooper JN
J Surg Res; 2018 Aug; 228():42-53. PubMed ID: 29907229
[TBL] [Abstract][Full Text] [Related]
20. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C.
Kaibori M; Matsui Y; Hijikawa T; Uchida Y; Kwon AH; Kamiyama Y
Surgery; 2006 Mar; 139(3):385-94. PubMed ID: 16546504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
